Blood stream infections after allogeneic stem cell transplantation: a single‐center experience with the use of levofloxacin prophylaxis
- 22 May 2011
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 14 (1) , 40-48
Abstract
A. Busca, I. Cavecchia, F. Locatelli, S. D' Ardia, F.G. De Rosa, F. Marmont, G. Ciccone, I. Baldi, R. Serra, E. Gaido, M. Falda. Blood stream infections after allogeneic stem cell transplantation: a single‐center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis 2011. All rights reserved Blood stream infections (BSIs) remain one of the major causes of morbidity and mortality for patients receiving an allogeneic hematopoietic stem cell transplantation (HSCT). In the present study, we evaluated the incidence and characteristics of BSI within 1 year after allogeneic HSCT in 269 consecutive adult patients who received antibacterial prophylaxis with levofloxacin. Cumulative incidence of BSI was 12% (95% confidence interval, 8–16%). Bacteria were responsible for 30 out of the 32 BSI, while fungi were responsible for 2 episodes of BSI. The median onset of BSI was day 8 (range 1–328 days) post transplant, and 66% of BSI occurred before neutrophil recovery. Gram‐positive organisms accounted for 60% (n=18) of bacteremia, and gram‐negative isolates for 40% (n=12) of the cases. Coagulase‐negative staphylococci were the most commonly isolated gram‐positive pathogens (53% of the cases), while Escherichia coli was the most commonly isolated gram‐negative bacteria (58% of the cases). Candida albicans and Candida guillermondii were isolated from patients with candidemia. Resistance to fluoroquinolones (FQ) was common with 13% of gram‐positive isolates being susceptible to FQ, while 50% of the gram‐negative rods were susceptible to FQ. Crude mortality and mortality attributable to BSI were both 3% (1 of 32). In conclusion, our data suggest that despite the emergence of antibiotic resistance, FQ prophylaxis may be considered an appealing approach in allogeneic HSCT recipients and is also worth evaluating in randomized studies.Keywords
This publication has 16 references indexed in Scilit:
- The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantationBone Marrow Transplantation, 2009
- Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2009
- Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortalityBone Marrow Transplantation, 2007
- The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unitBone Marrow Transplantation, 2007
- Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantationBone Marrow Transplantation, 2007
- Severe Infections after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Comparison of Cord Blood Transplantation with Peripheral Blood and Bone Marrow TransplantationTransplantation and Cellular Therapy, 2006
- Impact of Fluoroquinolone Prophylaxis on Reduced Infection‐Related Mortality among Patients with Neutropenia and Hematologic MalignanciesClinical Infectious Diseases, 2005
- Longitudinal Study of Bacterial, Viral, and Fungal Infections in Adult Recipients of Bone Marrow TransplantsClinical Infectious Diseases, 2001
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999